Literature DB >> 11377298

Pheochromocytoma.

H C Klingler1, P J Klingler, J K Martin, R C Smallridge, S L Smith, R A Hinder.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11377298     DOI： 10.1016/s0090-4295(01)00966-9

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  8 in total

1.  Surgical analysis of pediatric and adolescent sporadic pheochromocytoma: single center experience.

Authors:  Yasser Osman; Naser Hussein; Osama Sarhan; Ahmed A Shorrab; Mohamed Dawaba; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  HSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways.

Authors:  Feifei Xu; Dengqiang Lin; Wen Jiang; Li Meng; Yunze Xu; Chenghe Wang; Xiaojing Wang; Hongchao He; Danfeng Xu; Yu Zhu
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Heparanase-1 and Cyclooxygenase-2: prognostic indicators of malignancy in pheochromocytomas.

Authors:  Yu Zhu; Hong-chao He; Fei Yuan; Jun Zhang; Wen-bin Rui; Ju-ping Zhao; Zhou-jun Shen; Guang Ning
Journal:  Endocrine       Date:  2010-06-18       Impact factor: 3.633

4.  Pheochromocytoma management, outcomes and the role of cortical preservation.

Authors:  Alisha Gupta; Sandeep Agarwala; Nikhil Tandon; M Srinivas; Minu Bajpai; Devendra Kumar Gupta; Arun Kumar Gupta; Chandersekhar Bal; Rakesh Kumar; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-11-08       Impact factor: 1.967

5.  Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: A dual-centre study of 72 cases.

Authors:  Aude de Fourmestraux; Laurent Salomon; Claude-Clément Abbou; Philippe Grise
Journal:  World J Urol       Date:  2014-09-11       Impact factor: 4.226

6.  Laparoscopic treatment of hypertension after micturition: Bladder pheochromocytoma.

Authors:  Alp Bozbora; Umut Barbaros; Yesim Erbil; Isin Kiliçarslan; Esra Yildizhan; Selcuk Ozarmagan
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

7.  Paraganglioma of prostatic origin.

Authors:  B Padilla-Fernández; P Antúnez-Plaza; M F Lorenzo-Gómez; M Rodríguez-González; A Martín-Rodríguez; J M Silva-Abuín
Journal:  Clin Med Insights Case Rep       Date:  2012-05-21

8.  NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo.

Authors:  Jianpo Lian; Dengqiang Lin; Xing Xie; Yunze Xu; Lieyu Xu; Li Meng; Yu Zhu
Journal:  Onco Targets Ther       Date:  2017-04-19       Impact factor: 4.147
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.